Loading...
Futility Assessment of Recombinant Factor VII Activated for the Treatment of Hemorrhagic Shock Requiring Massive Transfusion
Objective: Recombinant human factor VII activated (rFVIIa) is an adjuvant therapy in patients receiving massive transfusion for hemorrhagic shock. We compared patient characteristics and outcomes to determine futility criteria for the administration of rFVIIa in patients receiving massive transfusio...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Thomas Land Publishers, Inc.
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3857122/ https://ncbi.nlm.nih.gov/pubmed/24421549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj4809-753 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|